세계의 입자선 치료 시장 : 치료 유형, 컴포넌트, 구성, 암 유형, 최종 사용자별 예측(2025-2030년)

The Particle Therapy Market was valued at USD 772.41 million in 2023, expected to reach USD 831.50 million in 2024, and is projected to grow at a CAGR of 7.94%, to USD 1,318.87 million by 2030.

Particle therapy, primarily comprising proton and heavy ion therapy, is a form of external beam radiotherapy utilizing charged particles for cancer treatment. Due to its precision in targeting tumors while minimizing damage to surrounding healthy tissues, it addresses a critical necessity in cancer treatment, reducing side effects associated with conventional radiation therapy. Applications span a variety of cancers, including pediatric, prostate, and head and neck cancers, with growing utility in treating ocular tumors and neurological disorders. End-use sectors primarily include healthcare facilities like specialized hospitals and cancer treatment centers.

Market growth is driven by technological advancements in treatment delivery systems, increasing incidence of cancer, rising awareness about advanced treatment options, and supportive government initiatives. Recent innovations in pencil beam scanning and intensity-modulated proton therapy have heightened treatment accuracy, presenting lucrative opportunities for companies investing in R&D. However, challenges such as high installation and operational costs, limited availability of facilities, and intricate regulatory approvals constrain market expansion. Additionally, the lack of skilled professionals poses a significant barrier in developing regions.

For businesses aiming to capitalize on growth opportunities, investing in cost-effective technologies and building collaborations with healthcare providers to establish new treatment centers are recommended. Furthermore, enhancing training programs and expanding into untapped emerging markets could foster broader accessibility and adoption of particle therapy.

The particle therapy market remains competitive, with innovation centered on improving clinical outcomes and reducing financial burdens for patients and providers. Companies focusing on developing hybrid therapy solutions and integrating AI for personalized treatment planning can stay at the forefront of the industry. Despite financial and logistical constraints, the market's trajectory remains promising, bolstered by continuous R&D efforts and evolving regulatory landscapes favoring advanced cancer therapies. Such advancements promise to reshape treatment paradigms and expand the potential for particle therapy applications worldwide.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Particle Therapy Market

The Particle Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Need for advanced therapies in cancer treatment
  • Rise in adoption of particle therapy in clinical trials
  • Growing number of particle therapy centers worldwide
• Market Restraints
  • High cost of particle therapy equipment and procedures, along with limited insurance coverage for particle therapy
• Market Opportunities
  • Ongoing proton therapy research programs
  • Technological advances in charged-particle therapy and enabling personalized cancer treatment strategies
• Market Challenges
  • Risk associated with the particle therapy radiation exposure

Porter's Five Forces: A Strategic Tool for Navigating the Particle Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Particle Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Particle Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Particle Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Particle Therapy Market

A detailed market share analysis in the Particle Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Particle Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Particle Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Particle Therapy Market

A strategic analysis of the Particle Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Particle Therapy Market, highlighting leading vendors and their innovative profiles. These include Advanced Oncotherapy plc, B dot Medical Inc., Best Particle Therapy, Inc., BioSig Technologies Inc., Covenant Health, Danfysik A/S, Elekta AB, Hitachi, Ltd., IBA International, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, New Mexico Cancer Center, Optivus Proton Therapy, Inc., P-Cure Ltd, ProTom International, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Shanghai APACTRON Particle Equipment Co., Ltd., Siemens Healthineers GmbH, Stantec Inc., Sumitomo Heavy Industries, Ltd., Toshiba Medical Systems Corporation, and Xstrahl Ltd..

Market Segmentation & Coverage

This research report categorizes the Particle Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Therapy Type, market is studied across Heavy Ion Therapy and Proton Therapy.
• Based on Component, market is studied across Product and Service. The Product is further studied across Cyclotrons, Synchrocyclotrons, and Synchrotrons.
• Based on Configuration, market is studied across Multi-room System and Single-room System.
• Based on Cancer Type, market is studied across Breast Cancer, Head & Neck Cancer, Lung Cancer, Pediatric Cancer, and Prostate Cancer.
• Based on End-User, market is studied across Ambulatory Surgery Centers and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Need for advanced therapies in cancer treatment
    • 5.1.1.2. Rise in adoption of particle therapy in clinical trials
    • 5.1.1.3. Growing number of particle therapy centers worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of particle therapy equipment and procedures, along with limited insurance coverage for particle therapy
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing proton therapy research programs
    • 5.1.3.2. Technological advances in charged-particle therapy and enabling personalized cancer treatment strategies
  • 5.1.4. Challenges
    • 5.1.4.1. Risk associated with the particle therapy radiation exposure
• 5.2. Market Segmentation Analysis
  • 5.2.1. Therapy Type: Consumer preference for proton therapy as it provides a reduced risk of damage to surrounding tissues
  • 5.2.2. Component: Rising utilization of product components for treating solid tumors near vital organs due to their high accuracy
  • 5.2.3. Configuration: Potential of a multi-room system for treating a larger number of patients concurrently
  • 5.2.4. Cancer Type: Expanding usage of particle therapy for head & neck cancer owing to reduced risk on healthy tissue
  • 5.2.5. End-User: Significant role of particle therapy in hospitals & clinicals as they strive to provide high-quality care
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Particle Therapy Market, by Therapy Type

• 6.1. Introduction
• 6.2. Heavy Ion Therapy
• 6.3. Proton Therapy

7. Particle Therapy Market, by Component

• 7.1. Introduction
• 7.2. Product
  • 7.2.1. Cyclotrons
  • 7.2.2. Synchrocyclotrons
  • 7.2.3. Synchrotrons
• 7.3. Service

8. Particle Therapy Market, by Configuration

• 8.1. Introduction
• 8.2. Multi-room System
• 8.3. Single-room System

9. Particle Therapy Market, by Cancer Type

• 9.1. Introduction
• 9.2. Breast Cancer
• 9.3. Head & Neck Cancer
• 9.4. Lung Cancer
• 9.5. Pediatric Cancer
• 9.6. Prostate Cancer

10. Particle Therapy Market, by End-User

• 10.1. Introduction
• 10.2. Ambulatory Surgery Centers
• 10.3. Hospitals & Clinics

11. Americas Particle Therapy Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Particle Therapy Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Particle Therapy Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. IBA and PARTICLE Initiate FLASH Proton Therapy Research Partnership
  • 14.3.2. P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel
  • 14.3.3. Terapet raises CHF 2.3 million for its next-generation cancer treatment technology
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Oncotherapy plc
• 2. B dot Medical Inc.
• 3. Best Particle Therapy, Inc.
• 4. BioSig Technologies Inc.
• 5. Covenant Health
• 6. Danfysik A/S
• 7. Elekta AB
• 8. Hitachi, Ltd.
• 9. IBA International
• 10. Koninklijke Philips N.V.
• 11. Mevion Medical Systems
• 12. Mitsubishi Electric Corporation
• 13. New Mexico Cancer Center
• 14. Optivus Proton Therapy, Inc.
• 15. P-Cure Ltd
• 16. ProTom International
• 17. Provision Healthcare, LLC
• 18. PTW Freiburg GmbH
• 19. SAH Global LLC
• 20. Shanghai APACTRON Particle Equipment Co., Ltd.
• 21. Siemens Healthineers GmbH
• 22. Stantec Inc.
• 23. Sumitomo Heavy Industries, Ltd.
• 24. Toshiba Medical Systems Corporation
• 25. Xstrahl Ltd.